Differential diagnosis of hepatic nodules using delayed parenchymal phase imaging of levovist contrast ultrasound: Comparative study with SPIO-MRI

Hepatology Research

Volumn 29, Issue 2, 2004, Pages 122-126

  Suzuki, Shiro ^a   Iijima, Hiroko ^a   Moriyasu, Fuminori ^a   Sasaki, Shunichi ^a   Yanagisawa, Kyosuke ^a   Miyahara, Takeo ^a   Oguma, Kazutake ^a   Yoshida, Masahiro ^a   Horibe, Toshiya ^a   Ito, Naoki ^a   Kakizaki, Dai ^a   Abe, Kimihiko ^a   Tsuchiya, Kaoru ^b  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b MUSASHINO RED CROSS HOSPITAL   (Japan)

Author keywords

Dedifferentiation; Dysplastic nodule; Hepatocellular carcinoma; Kupffer cell; Regenerative nodule

Indexed keywords

SHU 508; SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; KUPFFER CELL; LIVER CELL CARCINOMA; LIVER NODULE; LIVER PARENCHYMA; MACROPHAGE FUNCTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELIABILITY; RETICULOENDOTHELIAL SYSTEM; ULTRASOUND;

EID: 2442705520     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2004.02.010     Document Type: Article

References (13)

1. Tanaka M. Nakashima O. Wada Y. Kage M. Kojiro M. Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver Hepatology 244 1996 807-812
2. Tanimoto A. Yuasa Y. Shinmoto H. et al. Superparamagetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell function Radiology 2223 2002 661-666
3. Walday P. Tolleshaug H. Gjoen T. et al. Biodistributions of air-filled albumin microspheres in rats and pigs Biochem J 299Pt 2 1994 437
4. Fritzsch T, Heldmann D, Reinhardt M, The potential of a novel contrast medium. In: Goldberg G, editor. Ultrasound Contrast Agents. London: Dunitz; 1997. p 16.
5. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects revised by the 52nd WMA General Assembly, Venice, Italy; October 1983.
6. Oka H. Kurioka N. Kim K. et al. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis Hepatology 124 1990 680-687
7. Wilson S.R. Burns P.N. Muradali D. Wilson J.A. Lai X. Harmonic hepatic US with microbubble contrast agent: initial experimence showing improved characterization of hemangioma, hepatocellualr carcinoma, and metastasis Radiology 215 2000 153-161
8. Yucel C. Ozdemir H. Gurel S. Arac M. Detection and differential diagnosis of hepatic masses using pulse inversion harmonic imaging durning the liver-specific late phase of contrast enhanced with Levovist Jpn. Clin. Ultrasound 304 2002 203-212
9. Herbay A.V. Vogt C. Haussinger D. Late-phase pulse-inversion sonography using the contrast agent levovist: differentiation between benign and malignant focal lesions of the liver Am. J. Roentgenol. 1795 2002 1273-1279
10. Kim T.K. Choi B.I. Han J.K. Hong H.S. Park S.H. Moon S.G. Hepatic tumors: contrast-enhancement patterns with pulse inversion harmonic, US Radiology 216 2000 411-417
11. Lim J.H. Choi D. Cho S.K. et al. Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number Radiology 2203 2001 669-676
12. Forsberg F. Goldberg B.B. Liu J.B. Merton D.A. Rawool N.M. Shi W.T. Tissue-specific US contrast agent for evaluation of hepatic and splenic parenchyma Radiology 210 1999 125-132
13. Quaia E. Blomely M.J. Patel S. Initial observations on the effect of irradiation on the liver-specific uptake of Levovist Eur. J. Radiol. 413 2002 192-199